Optimizing Efficiency in TAVR: Large Bore Access Site Management

Watch Dr. Bruce Rutkin, System Director of Structural Heart Disease at North Shore University Hospital in Manhasset, New York share real case examples and personal experiences of Optimizing Efficiency in TAVR through Large Bore Access Site Management.

Learn from topics including:
- Patient & Vessel assessment
- Access technique
- Closure device selection
- Post-deployment assessment
- Bail-out options

Learn more about MANTA® Vascular Closure Device at:
https://Teleflex.com/MANTA

INDICATIONS FOR USE: The MANTA Vascular Closure Device is indicated for closure of femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures.

Please see the instructions for use for complete product information.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Not all products are available in all regions. Please contact customer service to confirm availability in your region.

Teleflex, the Teleflex logo, and MANTA are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks or registered trademarks are property of their respective owners.

©2020 Teleflex Incorporated. All rights reserved. MC-006858 Rev 0 11/20